You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

IMIPRAMINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Imipramine Hydrochloride, and what generic alternatives are available?

Imipramine Hydrochloride is a drug marketed by Novartis, Chartwell, Leading, Lederle, Oxford Pharms, Par Pharm, Roxane, Sandoz, Specgx Llc, Strides Pharma, Sun Pharm Industries, Teva, Usl Pharma, Vangard, Watson Labs, and West Ward. and is included in thirty-six NDAs.

The generic ingredient in IMIPRAMINE HYDROCHLORIDE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Imipramine Hydrochloride

A generic version of IMIPRAMINE HYDROCHLORIDE was approved as imipramine hydrochloride by STRIDES PHARMA on October 21st, 1983.

  Try a Trial

Drug patent expirations by year for IMIPRAMINE HYDROCHLORIDE
Recent Clinical Trials for IMIPRAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wright State UniversityPhase 1
Benha UniversityN/A
Wright State PhysiciansPhase 1

See all IMIPRAMINE HYDROCHLORIDE clinical trials

Pharmacology for IMIPRAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for IMIPRAMINE HYDROCHLORIDE

US Patents and Regulatory Information for IMIPRAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 085875-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sun Pharm Industries IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 081050-001 Jun 5, 1990 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 085877-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma IMIPRAMINE HYDROCHLORIDE imipramine hydrochloride TABLET;ORAL 088262-001 Oct 21, 1983 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.